SEVERE FORM OF CROHN’S DISEASE IN COMBINATION WITH AUTOIMMUNE LIVER DISEASE
https://doi.org/10.24884/0042-4625-2018-177-3-54-56
Abstract
The proven data on the dangerous using of drugs from the group of monoclonal antibodies to TNF-alpha in patients with Crohn’s disease, as well as methods of correction of the revealed homeostasis disorders are pre- sented.
About the Authors
G. I. SinenchenkoRussian Federation
S. S. Gaiduk
Russian Federation
M. I. Gromov
Russian Federation
A. V. Kosachev
Russian Federation
L. P. Pivovarova
Russian Federation
References
1. Adler G. Bolezn Krona i yazvennyi kolit / per. s nem. M.: GEHOTAR–MED, 2001. 500 p..
2. Sinenchenko G. I., Peregudov S. I., Tulupov A. N. Ehndolimfaticheskaya lekarstvennaya terapiya ostryh vospalitelnyh zabolevanij v neotlozhnoj abdominalnoj hirurgii. SPb.: DMITRIJ BULANIN, 2014. 192 p..
3. Belousova E. A. Yazvennyj kolit i bolezn Krona. M.: Triada, 2002. 128 p..
4. Gromov M. I., Pivovarova L. P. Primenenie immunomodulyatora derinat v lechenii hirurgicheskih bolnyh s tyazhelym sepsisom // Fundamentalnye issledo vaniya. 2012. № 7 (2). P. 289–295.
Review
For citations:
Sinenchenko G.I., Gaiduk S.S., Gromov M.I., Kosachev A.V., Pivovarova L.P. SEVERE FORM OF CROHN’S DISEASE IN COMBINATION WITH AUTOIMMUNE LIVER DISEASE. Grekov's Bulletin of Surgery. 2018;177(3):54-56. (In Russ.) https://doi.org/10.24884/0042-4625-2018-177-3-54-56